Task: Answer the multiple choice question.
Question: Which drug exhibits a -13.606% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CC(C)N(C(=O)Cn1cc(SCC(=O)NCC2CCCO2)c2ccccc21)C(C)C
b: Br.CN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1
c: Cc1cc(C)nc(SCc2cc(=O)c(OC(=O)c3cccc([N+](=O)[O-])c3)co2)n1
Answer: b. Br.CN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Br.CN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1
Br.CN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1
3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol;hydrobromide